INOTUZUMAB OZOGAMICIN

INOTUZUMAB OZOGAMICIN was reported 2992 times

INOTUZUMAB OZOGAMICIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BROAD LIGAMENT LEIOMYOMA 1 1.0000
1 HY'S LAW CASE 1 0.2000
2 EZH2 GENE MUTATION 1 0.2000
3 LINEAGE SWITCH LEUKAEMIA 9 0.1698
4 LEPTOMENINGEAL MYELOMATOSIS 2 0.1538
5 COSTAL CARTILAGE FRACTURE 5 0.1471
6 GLYCATED ALBUMIN INCREASED 2 0.1429
7 SYSTEMIC VIRAL INFECTION 2 0.1429
8 HAEMOPHILUS BACTERAEMIA 6 0.1224
9 PURTSCHER RETINOPATHY 7 0.0854
10 TRANSPLANT ASSOCIATED THROMBOTIC MICROANGIOPATHY 2 0.0800
11 LEUKAEMIC INFILTRATION EXTRAMEDULLARY 19 0.0745
12 PRECURSOR B-LYMPHOBLASTIC LYMPHOMA RECURRENT 2 0.0714
13 B PRECURSOR TYPE ACUTE LEUKAEMIA 27 0.0696
14 BONE MARROW LEUKAEMIC CELL INFILTRATION 5 0.0610
15 CELL-MEDIATED CYTOTOXICITY 3 0.0588
16 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 148 0.0573
17 VENOOCCLUSIVE DISEASE 132 0.0527
18 VENOOCCLUSIVE LIVER DISEASE 260 0.0526
19 ACHROMOBACTER INFECTION 6 0.0500
20 B-CELL TYPE ACUTE LEUKAEMIA 34 0.0463
21 SPONTANEOUS BACTERIAL PERITONITIS 11 0.0451
22 METAMYELOCYTE COUNT INCREASED 6 0.0403
23 CARDIAC AUTONOMIC NEUROPATHY 2 0.0385
24 CENTRAL NERVOUS SYSTEM LEUKAEMIA 15 0.0382
25 ACUTE LYMPHOCYTIC LEUKAEMIA REFRACTORY 5 0.0370
26 PHILADELPHIA POSITIVE ACUTE LYMPHOCYTIC LEUKAEMIA 6 0.0368
27 HEPATIC CALCIFICATION 6 0.0364
28 LEUKAEMIC INFILTRATION 5 0.0357
29 POST-DEPLETION B-CELL RECOVERY 4 0.0351
30 MYELOCYTE COUNT INCREASED 6 0.0319
31 HEPATIC VEIN OCCLUSION 5 0.0316
32 MATERNAL EXPOSURE VIA PARTNER DURING PREGNANCY 2 0.0312
33 HEPATOBILIARY INFECTION 1 0.0312
34 GRAFT VERSUS HOST DISEASE ORAL 2 0.0312
35 ADRENOMEGALY 6 0.0288
36 GLOSSOPHARYNGEAL NERVE DISORDER 1 0.0256
37 DEVICE RELATED BACTERAEMIA 7 0.0226
38 CORYNEBACTERIUM INFECTION 12 0.0224
39 BACILLUS CALMETTE-GUERIN INFECTION 1 0.0222
40 BLOOD PRESSURE AMBULATORY INCREASED 1 0.0217
41 BLAST CELLS PRESENT 10 0.0208
42 MINIMAL RESIDUAL DISEASE 10 0.0207
43 VITAMIN C DEFICIENCY 4 0.0205
44 MUCOCUTANEOUS HAEMORRHAGE 3 0.0201
45 DOUBLE HIT LYMPHOMA 1 0.0200
46 ENCEPHALITIS BACTERIAL 1 0.0196
47 HEPATOBILIARY DISEASE 12 0.0192
48 TRANSPLANTATION COMPLICATION 8 0.0190
49 DUODENAL POLYP 4 0.0189
50 PNEUMONIA NECROTISING 12 0.0185
51 COAGULATION FACTOR IX LEVEL DECREASED 1 0.0175
52 OPTIC DISC OEDEMA 2 0.0172
53 DISSEMINATED TOXOPLASMOSIS 2 0.0167
54 ACUTE LYMPHOCYTIC LEUKAEMIA 47 0.0166
55 METASTASES TO PANCREAS 7 0.0158
56 CROSSMATCH INCOMPATIBLE 1 0.0156
57 ACINETOBACTER SEPSIS 1 0.0156
58 B-CELL APLASIA 4 0.0155
59 BACTEROIDES TEST POSITIVE 1 0.0152
60 BLOOD BILIRUBIN 1 0.0149
61 ASPIRATION BONE MARROW ABNORMAL 2 0.0148
62 ENGRAFT FAILURE 4 0.0139
63 BLAST CELL COUNT DECREASED 1 0.0137
64 CSF WHITE BLOOD CELL COUNT POSITIVE 1 0.0135
65 BLOOD PRESSURE SYSTOLIC 1 0.0135
66 COAGULATION FACTOR X LEVEL DECREASED 1 0.0133
67 NEOPLASM RECURRENCE 45 0.0133
68 IMMUNE EFFECTOR CELL-ASSOCIATED HLH-LIKE SYNDROME 2 0.0132
69 ENDOTHELIAL DYSFUNCTION 3 0.0129
70 HYPERLEUKOCYTOSIS 11 0.0124
71 CYTOTOXIC CARDIOMYOPATHY 1 0.0122
72 COMPLEMENT FACTOR INCREASED 1 0.0119
73 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 2 0.0115
74 NODULAR REGENERATIVE HYPERPLASIA 7 0.0109
75 ACUTE BIPHENOTYPIC LEUKAEMIA 1 0.0108
76 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 7 0.0107
77 CHRONIC LYMPHOCYTIC LEUKAEMIA REFRACTORY 1 0.0106
78 ADENOVIRUS TEST POSITIVE 1 0.0105
79 FIBRIN DEGRADATION PRODUCTS INCREASED 3 0.0101
80 OVARIAN FAILURE 5 0.0093
81 CELLULITE 3 0.0092
82 AMYLASE DECREASED 1 0.0090
83 COAGULATION FACTOR VII LEVEL DECREASED 1 0.0089
84 ABDOMINAL REBOUND TENDERNESS 1 0.0089
85 SEPTIC EMBOLUS 7 0.0084
86 GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0084
87 CALCIUM IONISED DECREASED 2 0.0082
88 BUDD-CHIARI SYNDROME 2 0.0079
89 DIAPHRAGMATIC DISORDER 6 0.0078
90 VITAMIN B6 DECREASED 2 0.0078
91 DRAIN PLACEMENT 2 0.0078
92 ILEITIS 3 0.0078
93 BLOOD LACTIC ACID 1 0.0078
94 ENTEROCOCCAL BACTERAEMIA 8 0.0075
95 TRICHOSPORON INFECTION 3 0.0074
96 LYMPHOCYTIC LEUKAEMIA 3 0.0074
97 HYPERTROPHY 4 0.0074
98 CYTOKINE RELEASE SYNDROME 142 0.0071
99 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 15 0.0070
100 BURKHOLDERIA CEPACIA COMPLEX INFECTION 2 0.0070
101 ELECTROCARDIOGRAM QT INTERVAL 1 0.0069
102 ADENOVIRUS REACTIVATION 1 0.0069
103 BLOOD CHLORIDE INCREASED 12 0.0069
104 MYELOPATHY 13 0.0068
105 HEPATOSPLENIC CANDIDIASIS 1 0.0068
106 ESCHERICHIA BACTERAEMIA 16 0.0068
107 ENGRAFTMENT SYNDROME 4 0.0068
108 POLYCHROMASIA 2 0.0067
109 CYTOLOGY ABNORMAL 1 0.0067
110 BLOOD BRAIN BARRIER DEFECT 1 0.0066
111 BLOOD CREATININE 1 0.0065
112 HYPERPHOSPHATAEMIA 14 0.0065
113 ENTEROCOLITIS INFECTIOUS 6 0.0065
114 DACRYOCYSTITIS 1 0.0065
115 ASPERGILLUS TEST POSITIVE 2 0.0065
116 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 6 0.0065
117 GASTROENTERITIS ADENOVIRUS 1 0.0064
118 GRAFT VERSUS HOST DISEASE IN SKIN 14 0.0063
119 CENTRAL NERVOUS SYSTEM NEOPLASM 1 0.0062
120 GRAFT VERSUS HOST DISEASE 43 0.0060
121 PROCALCITONIN INCREASED 7 0.0060
122 LEUKAEMIA RECURRENT 10 0.0059
123 HUMAN HERPESVIRUS 6 INFECTION 11 0.0058
124 ACUTE MYELOID LEUKAEMIA REFRACTORY 1 0.0058
125 CHRONIC GRAFT VERSUS HOST DISEASE 21 0.0058
126 CHRONIC GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0058
127 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 34 0.0057
128 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 8 0.0057
129 BILE ACIDS INCREASED 1 0.0056
130 VIRAL HAEMORRHAGIC CYSTITIS 4 0.0056
131 SYSTEMIC CANDIDA 14 0.0056
132 ACUTE GRAFT VERSUS HOST DISEASE 25 0.0055
133 HYDROCHOLECYSTIS 1 0.0054
134 PANCREATIC ENLARGEMENT 2 0.0054
135 ACINETOBACTER BACTERAEMIA 1 0.0053
136 VARICELLA ZOSTER VIRUS INFECTION 11 0.0053
137 KLEBSIELLA BACTERAEMIA 5 0.0053
138 CYSTITIS VIRAL 2 0.0052
139 LOWER RESPIRATORY TRACT INFECTION FUNGAL 2 0.0051
140 GRAFT COMPLICATION 3 0.0051
141 FEBRILE INFECTION 6 0.0051
142 DUODENAL PERFORATION 5 0.0051
143 CD8 LYMPHOCYTES DECREASED 1 0.0050
144 CHRONIC GRAFT VERSUS HOST DISEASE IN EYE 1 0.0049
145 MONOCYTE COUNT DECREASED 6 0.0049
146 REMISSION NOT ACHIEVED 3 0.0048
147 CYTOPENIA 59 0.0048
148 BULLOUS HAEMORRHAGIC DERMATOSIS 1 0.0048
149 CHLOROMA 2 0.0047
150 HEPATORENAL SYNDROME 8 0.0047
151 POLYOMAVIRUS VIRAEMIA 5 0.0047
152 NITRITE URINE PRESENT 2 0.0046
153 PNEUMONIA FUNGAL 18 0.0046
154 JUGULAR VEIN THROMBOSIS 8 0.0045
155 NEOPLASM PROGRESSION 155 0.0045
156 BLOOD FIBRINOGEN DECREASED 5 0.0044
157 PNEUMONIA KLEBSIELLA 8 0.0043
158 ARACHNOIDITIS 3 0.0043
159 GRAFT VERSUS HOST DISEASE IN EYE 1 0.0043
160 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 4 0.0043
161 FUSARIUM INFECTION 3 0.0043
162 BONE MARROW NECROSIS 1 0.0043
163 H1N1 INFLUENZA 6 0.0043
164 FLUID IMBALANCE 3 0.0043
165 ADENOVIRAL HEPATITIS 1 0.0043
166 BONE MARROW TRANSPLANT 8 0.0042
167 CANCER FATIGUE 1 0.0042
168 MENINGITIS BACTERIAL 6 0.0042
169 PARASOMNIA 3 0.0042
170 ENTEROCOCCAL INFECTION 20 0.0041
171 ADENOVIRUS INFECTION 12 0.0041
172 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 1 0.0041
173 ENTEROBACTER TEST POSITIVE 1 0.0041
174 FEBRILE NEUTROPENIA 267 0.0040
175 BRAIN STEM SYNDROME 3 0.0040
176 ACUTE MYELOMONOCYTIC LEUKAEMIA 1 0.0040
177 COMPLICATIONS OF TRANSPLANT SURGERY 2 0.0040
178 CYTOMEGALOVIRUS GASTRITIS 1 0.0040
179 INFESTATION 1 0.0039
180 SKIN CANDIDA 2 0.0038
181 CYTOGENETIC ANALYSIS ABNORMAL 4 0.0038
182 TUMOUR LYSIS SYNDROME 33 0.0037
183 SINUSITIS FUNGAL 3 0.0037
184 GALLBLADDER ENLARGEMENT 4 0.0037
185 COOMBS TEST POSITIVE 1 0.0037
186 COAGULATION FACTOR DECREASED 1 0.0037
187 ANTITHROMBIN III DECREASED 1 0.0037
188 BONE MARROW DISORDER 11 0.0036
189 BLOOD PH INCREASED 2 0.0036
190 BK VIRUS INFECTION 12 0.0036
191 MEDICAL DEVICE SITE PAIN 2 0.0036
192 HAEMORRHAGIC ASCITES 1 0.0035
193 CARBON DIOXIDE DECREASED 4 0.0035
194 PLEOCYTOSIS 2 0.0034
195 GALLBLADDER OEDEMA 1 0.0034
196 CAPILLARY LEAK SYNDROME 7 0.0034
197 NEUTROPENIC SEPSIS 23 0.0032
198 RETINAL EXUDATES 3 0.0032
199 CARBON DIOXIDE ABNORMAL 1 0.0032
200 CYSTOID MACULAR OEDEMA 6 0.0032
201 THROMBOTIC MICROANGIOPATHY 31 0.0032
202 RECTAL FISSURE 2 0.0032
203 BACILLUS INFECTION 2 0.0032
204 NEUROTOXICITY 55 0.0031
205 HYPERBILIRUBINAEMIA 32 0.0031
206 BLOOD IMMUNOGLOBULIN A DECREASED 2 0.0031
207 HEPATITIS ALCOHOLIC 1 0.0031
208 OBLITERATIVE BRONCHIOLITIS 4 0.0030
209 BLOOD LACTIC ACID INCREASED 16 0.0030
210 BLOOD BILIRUBIN INCREASED 82 0.0030
211 BLOOD LACTATE DEHYDROGENASE DECREASED 1 0.0030
212 ENTEROBACTER INFECTION 5 0.0030
213 STENOTROPHOMONAS INFECTION 4 0.0029
214 CYTOKINE STORM 2 0.0029
215 DEMYELINATING POLYNEUROPATHY 3 0.0029
216 SPLENIC INFARCTION 5 0.0029
217 MULTIPLE ORGAN DYSFUNCTION SYNDROME 81 0.0029
218 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
219 HERPES ZOSTER MENINGOENCEPHALITIS 1 0.0028
220 COMPLICATIONS OF BONE MARROW TRANSPLANT 1 0.0028
221 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 14 0.0028
222 STREPTOCOCCAL BACTERAEMIA 3 0.0028
223 TOXIC LEUKOENCEPHALOPATHY 2 0.0028
224 BLOOD FOLATE DECREASED 2 0.0028
225 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 1 0.0027
226 CYTOMEGALOVIRUS OESOPHAGITIS 1 0.0027
227 HUMORAL IMMUNE DEFECT 1 0.0027
228 MUCORMYCOSIS 7 0.0027
229 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
230 DISSEMINATED CRYPTOCOCCOSIS 2 0.0026
231 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
232 PARAINFLUENZAE VIRUS INFECTION 4 0.0026
233 HERPES SIMPLEX REACTIVATION 1 0.0026
234 HAEMANGIOMA 6 0.0026
235 PORTAL HYPERTENSION 8 0.0026
236 ACUTE PRERENAL FAILURE 3 0.0026
237 RESTRICTIVE PULMONARY DISEASE 3 0.0026
238 PANCREATITIS CHRONIC 6 0.0025
239 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0025
240 ESCHERICHIA TEST POSITIVE 3 0.0025
241 SCLERODERMA 9 0.0025
242 RETICULOCYTE COUNT INCREASED 2 0.0025
243 BRONCHOPULMONARY ASPERGILLOSIS 19 0.0024
244 SECOND PRIMARY MALIGNANCY 20 0.0024
245 INFUSION SITE OEDEMA 2 0.0024
246 VITREOUS OPACITIES 2 0.0024
247 LACTOSE INTOLERANCE 6 0.0023
248 INFLUENZA A VIRUS TEST POSITIVE 1 0.0023
249 RHINOVIRUS INFECTION 9 0.0023
250 STAPHYLOCOCCAL BACTERAEMIA 10 0.0023
251 GASTROINTESTINAL TOXICITY 11 0.0023
252 SERUM FERRITIN INCREASED 12 0.0023
253 ANAEMIA MEGALOBLASTIC 1 0.0022
254 CHRONIC MYELOID LEUKAEMIA TRANSFORMATION 1 0.0022
255 PLASMA CELL MYELOMA REFRACTORY 3 0.0022
256 HEPATIC ATROPHY 1 0.0022
257 CYSTITIS HAEMORRHAGIC 9 0.0022
258 SHOCK HAEMORRHAGIC 18 0.0022
259 SUBDURAL HAEMATOMA 31 0.0022
260 DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION 1 0.0021
261 URINARY TRACT INFECTION ENTEROCOCCAL 2 0.0021
262 ASCITES 63 0.0021
263 BILIRUBIN CONJUGATED INCREASED 5 0.0021
264 HEPATOTOXICITY 47 0.0021
265 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
266 INTRA-ABDOMINAL HAEMORRHAGE 5 0.0021
267 GRAFT VERSUS HOST DISEASE IN LUNG 1 0.0021
268 PULMONARY SEPSIS 3 0.0021
269 BLOOD URIC ACID DECREASED 1 0.0021
270 GENE MUTATION 4 0.0020
271 HYPOFIBRINOGENAEMIA 2 0.0020
272 ELECTROCARDIOGRAM QT INTERVAL ABNORMAL 1 0.0020
273 CSF TEST ABNORMAL 1 0.0020
274 BRAIN ABSCESS 5 0.0020
275 ASPARTATE AMINOTRANSFERASE ABNORMAL 3 0.0020
276 HEPATOSPLENOMEGALY 5 0.0019
277 BLADDER OBSTRUCTION 1 0.0019
278 BRAIN NATRIURETIC PEPTIDE INCREASED 6 0.0019
279 BACTERAEMIA 23 0.0019
280 FOCAL NODULAR HYPERPLASIA 1 0.0019
281 LYMPHOCYTE COUNT DECREASED 34 0.0019
282 BLAST CELL COUNT INCREASED 2 0.0019
283 MUCOSAL INFLAMMATION 50 0.0019
284 FUNGAEMIA 3 0.0019
285 BLOOD ALBUMIN DECREASED 15 0.0019
286 HYPERTRIGLYCERIDAEMIA 11 0.0019
287 HEPATIC PAIN 8 0.0019
288 IRON OVERLOAD 2 0.0019
289 TOXOPLASMOSIS 2 0.0019
290 OESOPHAGEAL VARICES HAEMORRHAGE 4 0.0018
291 CRYSTALLURIA 1 0.0018
292 KIDNEY ENLARGEMENT 2 0.0018
293 CHRONIC MYELOID LEUKAEMIA RECURRENT 1 0.0018
294 INTERLEUKIN LEVEL INCREASED 1 0.0018
295 BLOOD MAGNESIUM ABNORMAL 1 0.0018
296 HYPOALBUMINAEMIA 14 0.0018
297 TOXIC ENCEPHALOPATHY 9 0.0018
298 GASTRIC POLYPS 4 0.0018
299 CEREBRAL VENTRICLE DILATATION 2 0.0017
300 HEPATOMEGALY 17 0.0017
301 MUCOSAL HAEMORRHAGE 2 0.0017
302 SYSTEMIC MYCOSIS 2 0.0017
303 GASTROINTESTINAL OEDEMA 3 0.0017
304 RED CELL DISTRIBUTION WIDTH INCREASED 7 0.0017
305 ASPERGILLUS INFECTION 11 0.0017
306 PROTHROMBIN TIME PROLONGED 10 0.0017
307 VARICES OESOPHAGEAL 5 0.0017
308 METAMORPHOPSIA 3 0.0016
309 PHARYNGEAL HAEMORRHAGE 2 0.0016
310 BLOOD BILIRUBIN DECREASED 1 0.0016
311 HYPERTRANSAMINASAEMIA 11 0.0016
312 TESTICULAR SWELLING 2 0.0016
313 MALLORY-WEISS SYNDROME 2 0.0016
314 ENCEPHALOPATHY 38 0.0015
315 ENTEROCOCCUS TEST POSITIVE 1 0.0015
316 SLOW RESPONSE TO STIMULI 2 0.0015
317 ABDOMINAL OPERATION 2 0.0015
318 HYPERMAGNESAEMIA 1 0.0015
319 APLASIA 3 0.0015
320 HYPOGAMMAGLOBULINAEMIA 10 0.0015
321 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 2 0.0015
322 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
323 ANION GAP INCREASED 2 0.0015
324 DEVICE RELATED SEPSIS 3 0.0015
325 HYPOPHOSPHATAEMIA 11 0.0015
326 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
327 BONE MARROW FAILURE 30 0.0015
328 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 11 0.0015
329 EFFUSION 2 0.0015
330 CARDIOTOXICITY 13 0.0015
331 ATRIAL THROMBOSIS 3 0.0014
332 NEUTROPENIC COLITIS 3 0.0014
333 MYELOSUPPRESSION 52 0.0014
334 CRANIAL NERVE DISORDER 1 0.0014
335 LUNG CONSOLIDATION 4 0.0014
336 NEUTROPHIL COUNT DECREASED 58 0.0014
337 CD4 LYMPHOCYTES DECREASED 3 0.0014
338 CEREBELLAR HAEMORRHAGE 2 0.0014
339 PELVIC VENOUS THROMBOSIS 2 0.0014
340 ENTEROCOLITIS 8 0.0014
341 ESCHERICHIA SEPSIS 4 0.0014
342 BLOOD BILIRUBIN UNCONJUGATED INCREASED 1 0.0014
343 THROMBOCYTOPENIA 154 0.0014
344 AMMONIA INCREASED 7 0.0014
345 HAEMATOTOXICITY 13 0.0014
346 CYTOMEGALOVIRUS INFECTION REACTIVATION 6 0.0014
347 AMYLASE INCREASED 5 0.0014
348 CHLAMYDIAL INFECTION 1 0.0013
349 METASTASES TO MENINGES 3 0.0013
350 CYTOMEGALOVIRUS COLITIS 3 0.0013
351 DUODENITIS 4 0.0013
352 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
353 MEAN CELL VOLUME DECREASED 2 0.0013
354 CHONDROCALCINOSIS PYROPHOSPHATE 1 0.0013
355 EXTRADURAL ABSCESS 1 0.0013
356 BLOOD FIBRINOGEN INCREASED 1 0.0013
357 HYPERGLYCAEMIA 46 0.0013
358 BLOOD LACTATE DEHYDROGENASE INCREASED 20 0.0013
359 PHARYNGEAL PARAESTHESIA 2 0.0013
360 PNEUMONIA VIRAL 4 0.0013
361 BARRETT'S OESOPHAGUS 1 0.0012
362 PORTAL VEIN THROMBOSIS 4 0.0012
363 SEPSIS 138 0.0012
364 INCISION SITE HAEMORRHAGE 1 0.0012
365 BACTERIAL SEPSIS 4 0.0012
366 LIVER FUNCTION TEST INCREASED 26 0.0012
367 HYDROTHORAX 1 0.0012
368 VENA CAVA THROMBOSIS 2 0.0012
369 LYMPHOPENIA 17 0.0012
370 HEPATITIS A 1 0.0012
371 ESCHERICHIA URINARY TRACT INFECTION 5 0.0012
372 PSEUDOMONAS INFECTION 10 0.0012
373 HEPATIC FIBROSIS 4 0.0012
374 ENTEROVIRUS INFECTION 1 0.0012
375 HEPATITIS TOXIC 3 0.0012
376 HILAR LYMPHADENOPATHY 1 0.0011
377 PLATELET COUNT DECREASED 121 0.0011
378 MITRAL VALVE DISEASE 2 0.0011
379 HYPERPLASIA 1 0.0011
380 ACUTE HEPATIC FAILURE 15 0.0011
381 HEPATIC FAILURE 33 0.0011
382 VENTRICULAR ARRHYTHMIA 4 0.0011
383 SOFT TISSUE INFECTION 2 0.0011
384 CERUMEN IMPACTION 1 0.0011
385 ASPARTATE AMINOTRANSFERASE INCREASED 58 0.0011
386 PNEUMOPERITONEUM 2 0.0011
387 HERPES SIMPLEX 7 0.0011
388 LEUKOENCEPHALOPATHY 4 0.0011
389 WHITE BLOOD CELLS URINE POSITIVE 2 0.0011
390 PROTEIN TOTAL DECREASED 4 0.0011
391 GUN SHOT WOUND 2 0.0011
392 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 4 0.0010
393 PARAPLEGIA 3 0.0010
394 HEPATIC MASS 2 0.0010
395 CYTOMEGALOVIRUS INFECTION 17 0.0010
396 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
397 MULTI-ORGAN DISORDER 2 0.0010
398 COVID-19 PNEUMONIA 12 0.0010
399 DEVICE RELATED THROMBOSIS 1 0.0010
400 HYPERVOLAEMIA 5 0.0010
401 DIPLEGIA 2 0.0010
402 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
403 METABOLIC ENCEPHALOPATHY 3 0.0010
404 ACQUIRED HAEMOPHILIA 1 0.0010
405 TRANSAMINASES INCREASED 22 0.0010
406 METASTASIS 7 0.0010
407 DYSAESTHESIA 3 0.0010
408 CORONAVIRUS TEST POSITIVE 1 0.0010
409 MYELODYSPLASTIC SYNDROME 14 0.0010
410 HYPONATRAEMIA 54 0.0010
411 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
412 ALANINE AMINOTRANSFERASE ABNORMAL 2 0.0009
413 PANCYTOPENIA 53 0.0009
414 ACUTE MYELOID LEUKAEMIA RECURRENT 2 0.0009
415 MYOPATHY 8 0.0009
416 PYELONEPHRITIS 8 0.0009
417 SEPTIC SHOCK 40 0.0009
418 BLADDER DILATATION 1 0.0009
419 LIPASE INCREASED 7 0.0009
420 DEVICE RELATED INFECTION 14 0.0009
421 ARTERIOSCLEROSIS CORONARY ARTERY 6 0.0009
422 EPSTEIN-BARR VIRAEMIA 1 0.0009
423 CYTOMEGALOVIRUS VIRAEMIA 4 0.0009
424 MENINGITIS 6 0.0009
425 NEUTROPENIA 122 0.0009
426 ALANINE AMINOTRANSFERASE INCREASED 55 0.0009
427 PSEUDOMEMBRANOUS COLITIS 2 0.0009
428 INFECTION REACTIVATION 1 0.0009
429 CENTRAL NERVOUS SYSTEM INFECTION 1 0.0009
430 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
431 NEUROLOGICAL DECOMPENSATION 2 0.0009
432 ERYTHEMA NODOSUM 3 0.0009
433 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 2 0.0009
434 CLOSTRIDIUM DIFFICILE COLITIS 9 0.0008
435 BLOOD ALKALINE PHOSPHATASE INCREASED 21 0.0008
436 FIBRIN D DIMER INCREASED 3 0.0008
437 HAEMORRHAGIC DIATHESIS 3 0.0008
438 DIABETES INSIPIDUS 2 0.0008
439 MENTAL STATUS CHANGES 23 0.0008
440 CLOSTRIDIUM COLITIS 1 0.0008
441 THERAPY NON-RESPONDER 37 0.0008
442 GAMMA-GLUTAMYLTRANSFERASE INCREASED 18 0.0008
443 BLAST CRISIS IN MYELOGENOUS LEUKAEMIA 1 0.0008
444 BLOOD MAGNESIUM DECREASED 7 0.0008
445 HYPERNATRAEMIA 4 0.0008
446 HEPATIC NECROSIS 3 0.0008
447 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0008
448 KLEBSIELLA INFECTION 4 0.0008
449 GLUCOSE URINE PRESENT 1 0.0008
450 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
451 BLOOD BILIRUBIN ABNORMAL 1 0.0008
452 CACHEXIA 4 0.0008
453 PHYSICAL DECONDITIONING 2 0.0008
454 BLOOD CHLORIDE DECREASED 2 0.0008
455 ACUTE MYELOID LEUKAEMIA 12 0.0008
456 EXPOSURE VIA FATHER 1 0.0008
457 DRUG CLEARANCE DECREASED 1 0.0008
458 CORONAVIRUS INFECTION 5 0.0008
459 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
460 ADRENAL INSUFFICIENCY 9 0.0007
461 BLOOD SODIUM INCREASED 2 0.0007
462 BODY MASS INDEX INCREASED 1 0.0007
463 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
464 SUBDURAL HAEMORRHAGE 2 0.0007
465 CLONUS 2 0.0007
466 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 6 0.0007
467 ILEUS 9 0.0007
468 EMBOLISM 6 0.0007
469 NEPHROPATHY TOXIC 8 0.0007
470 ALVEOLITIS 1 0.0007
471 LUNG INFECTION 11 0.0007
472 FEBRILE BONE MARROW APLASIA 3 0.0007
473 THERAPY PARTIAL RESPONDER 11 0.0007
474 FACIAL PARALYSIS 6 0.0007
475 GENITAL RASH 1 0.0007
476 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
477 WHITE BLOOD CELL COUNT DECREASED 75 0.0007
478 BLOOD CALCIUM INCREASED 6 0.0007
479 ENTEROCOLITIS HAEMORRHAGIC 1 0.0007
480 HEPATITIS FULMINANT 2 0.0007
481 ILEUS PARALYTIC 3 0.0007
482 HYPOKALAEMIA 31 0.0007
483 HEPATIC FUNCTION ABNORMAL 25 0.0007
484 BLOOD CULTURE POSITIVE 2 0.0007
485 HYDRONEPHROSIS 5 0.0007
486 INFECTION 96 0.0007
487 CENTRAL VENOUS CATHETERISATION 2 0.0007
488 LOWER RESPIRATORY TRACT INFECTION 30 0.0007
489 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
490 HYPOMAGNESAEMIA 9 0.0006
491 HEPATIC ENCEPHALOPATHY 6 0.0006
492 OESOPHAGITIS 7 0.0006
493 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
494 HEPATIC CIRRHOSIS 12 0.0006
495 BLOOD CREATININE DECREASED 2 0.0006
496 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
497 NON-SMALL CELL LUNG CANCER 3 0.0006
498 CUSHINGOID 2 0.0006
499 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
500 ACUTE LEUKAEMIA 1 0.0006
501 CRYPTOCOCCOSIS 1 0.0006
502 LIVER DISORDER 27 0.0006
503 SHOCK 14 0.0006
504 STAPHYLOCOCCAL INFECTION 20 0.0006
505 OTITIS MEDIA 2 0.0006
506 HAEMORRHAGE INTRACRANIAL 9 0.0006
507 HYPERAMMONAEMIA 3 0.0006
508 EROSIVE OESOPHAGITIS 1 0.0006
509 GAZE PALSY 1 0.0006
510 DRUG RESISTANCE 15 0.0006
511 ACUTE SINUSITIS 1 0.0006
512 DRUG-INDUCED LIVER INJURY 18 0.0006
513 PYREXIA 198 0.0006
514 THROMBOPHLEBITIS 2 0.0006
515 DUODENAL ULCER 4 0.0006
516 SINUS TACHYCARDIA 8 0.0006
517 RETINAL HAEMORRHAGE 4 0.0006
518 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
519 ANAL INCONTINENCE 5 0.0006
520 BLOOD PHOSPHORUS DECREASED 2 0.0005
521 FULL BLOOD COUNT DECREASED 11 0.0005
522 UROSEPSIS 5 0.0005
523 BODY TEMPERATURE INCREASED 11 0.0005
524 BACTERIAL INFECTION 10 0.0005
525 MACULAR OEDEMA 3 0.0005
526 SKIN INFECTION 6 0.0005
527 PULMONARY ALVEOLAR HAEMORRHAGE 3 0.0005
528 PANCREATITIS 28 0.0005
529 PERONEAL NERVE PALSY 3 0.0005
530 BILE DUCT OBSTRUCTION 1 0.0005
531 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
532 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
533 C-REACTIVE PROTEIN INCREASED 19 0.0005
534 CHOLESTASIS 10 0.0005
535 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
536 CONCOMITANT DISEASE PROGRESSION 1 0.0005
537 TESTIS CANCER 2 0.0005
538 HYPOGEUSIA 1 0.0005
539 HYPERAEMIA 1 0.0005
540 CEREBRAL ATROPHY 2 0.0005
541 TRANSPLANT REJECTION 4 0.0005
542 ORGAN FAILURE 2 0.0005
543 HEPATOCELLULAR INJURY 7 0.0005
544 RECURRENT CANCER 2 0.0005
545 EUPHORIC MOOD 5 0.0005
546 HYPERURICAEMIA 2 0.0005
547 ESCHERICHIA INFECTION 4 0.0005
548 COAGULOPATHY 8 0.0005
549 BLOOD UREA INCREASED 8 0.0005
550 HYPOCALCAEMIA 9 0.0005
551 EYE CONTUSION 1 0.0005
552 FULL BLOOD COUNT ABNORMAL 5 0.0005
553 HEPATIC CYTOLYSIS 6 0.0005
554 ENTERITIS 3 0.0005
555 HAEMATURIA 16 0.0005
556 ANURIA 4 0.0005
557 HEPATITIS ACUTE 3 0.0005
558 CHAPPED LIPS 2 0.0005
559 INFECTION SUSCEPTIBILITY INCREASED 1 0.0005
560 CLOSTRIDIUM TEST POSITIVE 1 0.0005
561 FAECES PALE 1 0.0004
562 CHOLESTATIC LIVER INJURY 1 0.0004
563 COLITIS 17 0.0004
564 STOMATITIS 27 0.0004
565 PAPILLOEDEMA 2 0.0004
566 BLOOD LOSS ANAEMIA 1 0.0004
567 DISTRIBUTIVE SHOCK 1 0.0004
568 GINGIVAL BLEEDING 6 0.0004
569 IMMUNE THROMBOCYTOPENIA 2 0.0004
570 ENCEPHALITIS 3 0.0004
571 CHRONIC MYELOID LEUKAEMIA 2 0.0004
572 ARTHRITIS INFECTIVE 2 0.0004
573 EYELID OEDEMA 5 0.0004
574 ANAEMIA 82 0.0004
575 VIRAL UPPER RESPIRATORY TRACT INFECTION 2 0.0004
576 NEUROPATHY PERIPHERAL 40 0.0004
577 LEUKOPENIA 21 0.0004
578 DEATH 360 0.0004
579 NERVOUS SYSTEM DISORDER 13 0.0004
580 RESPIRATORY FAILURE 30 0.0004
581 MOUTH HAEMORRHAGE 3 0.0004
582 HAEMATOLOGICAL INFECTION 1 0.0004
583 HYPERCALCAEMIA 5 0.0004
584 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
585 ABDOMINAL TENDERNESS 2 0.0004
586 PROTEIN URINE PRESENT 2 0.0004
587 PLEURAL EFFUSION 24 0.0004
588 ABDOMINAL INFECTION 1 0.0004
589 SKIN ULCER 10 0.0004
590 FAILURE TO THRIVE 2 0.0004
591 ACUTE KIDNEY INJURY 58 0.0004
592 DISEASE RECURRENCE 18 0.0004
593 AREFLEXIA 1 0.0004
594 HYPOXIA 13 0.0004
595 POLYURIA 3 0.0004
596 BLOOD PHOSPHORUS INCREASED 1 0.0004
597 BLOOD POTASSIUM DECREASED 11 0.0004
598 ACUTE RESPIRATORY FAILURE 7 0.0004
599 DISEASE PROGRESSION 43 0.0004
600 RESPIRATORY DISTRESS 10 0.0004
601 MALNUTRITION 4 0.0004
602 ACUTE PULMONARY OEDEMA 2 0.0004
603 CANDIDA INFECTION 6 0.0004
604 HAEMATOLOGICAL MALIGNANCY 1 0.0004
605 NEOPLASM 4 0.0003
606 HAEMATOMA 9 0.0003
607 SEIZURE 40 0.0003
608 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
609 HYPOVOLAEMIA 2 0.0003
610 CHOLECYSTITIS 4 0.0003
611 HAEMOLYTIC ANAEMIA 3 0.0003
612 ATYPICAL PNEUMONIA 1 0.0003
613 PLATELET COUNT ABNORMAL 2 0.0003
614 FUNGAL INFECTION 11 0.0003
615 BLOOD COUNT ABNORMAL 5 0.0003
616 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
617 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
618 PNEUMONIA BACTERIAL 3 0.0003
619 FIBROSIS 1 0.0003
620 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
621 INFUSION SITE EXTRAVASATION 2 0.0003
622 DIARRHOEA HAEMORRHAGIC 3 0.0003
623 EPISTAXIS 24 0.0003
624 FLANK PAIN 3 0.0003
625 LEUKAEMIA 3 0.0003
626 BRAIN OEDEMA 4 0.0003
627 RED BLOOD CELL COUNT DECREASED 9 0.0003
628 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
629 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
630 PROCTALGIA 2 0.0003
631 LYMPHADENOPATHY 11 0.0003
632 ATELECTASIS 3 0.0003
633 ORAL HERPES 6 0.0003
634 CEREBRAL HAEMORRHAGE 11 0.0003
635 DYSGRAPHIA 2 0.0003
636 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1 0.0003
637 TREATMENT FAILURE 25 0.0003
638 ANXIETY DISORDER 1 0.0003
639 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
640 JAUNDICE 8 0.0003
641 PNEUMONIA 96 0.0003
642 TACHYPNOEA 4 0.0003
643 PNEUMONITIS 8 0.0003
644 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 3 0.0003
645 INTERSTITIAL LUNG DISEASE 14 0.0003
646 LUNG DISORDER 14 0.0003
647 PULMONARY TOXICITY 2 0.0003
648 MOVEMENT DISORDER 9 0.0003
649 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
650 LACTIC ACIDOSIS 9 0.0003
651 BONE LESION 1 0.0003
652 CUTANEOUS VASCULITIS 1 0.0003
653 HEPATITIS 7 0.0003
654 CHILLS 32 0.0003
655 OFF LABEL USE 232 0.0003
656 APHASIA 8 0.0003
657 PROTEINURIA 5 0.0003
658 PERICARDIAL EFFUSION 6 0.0003
659 HAEMOLYSIS 2 0.0003
660 ELECTROLYTE IMBALANCE 3 0.0003
661 FAECES HARD 1 0.0003
662 APNOEA 2 0.0003
663 CARDIOPULMONARY FAILURE 1 0.0003
664 SPLENOMEGALY 3 0.0003
665 PULMONARY HAEMORRHAGE 2 0.0003
666 HAEMOGLOBIN DECREASED 26 0.0003
667 AZOTAEMIA 1 0.0003
668 SENSORY LOSS 2 0.0002
669 PHARYNGITIS 3 0.0002
670 GASTROINTESTINAL PERFORATION 1 0.0002
671 OEDEMA 13 0.0002
672 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 7 0.0002
673 MUSCULAR WEAKNESS 27 0.0002
674 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
675 ABSCESS LIMB 1 0.0002
676 SKIN HYPERPIGMENTATION 2 0.0002
677 HEPATIC LESION 1 0.0002
678 ALTERED STATE OF CONSCIOUSNESS 5 0.0002
679 HYPERKALAEMIA 8 0.0002
680 MELAENA 5 0.0002
681 IMMUNOSUPPRESSION 2 0.0002
682 GASTROINTESTINAL INFECTION 2 0.0002
683 CONFUSIONAL STATE 36 0.0002
684 PANCREATITIS ACUTE 5 0.0002
685 LEUKOCYTOSIS 4 0.0002
686 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
687 PATHOGEN RESISTANCE 2 0.0002
688 DISEASE COMPLICATION 1 0.0002
689 RENAL FAILURE 29 0.0002
690 CELLULITIS 11 0.0002
691 COVID-19 38 0.0002
692 INTERCEPTED MEDICATION ERROR 1 0.0002
693 GASTRITIS EROSIVE 1 0.0002
694 HYPOTENSION 42 0.0002
695 GUILLAIN-BARRE SYNDROME 1 0.0002
696 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
697 LIVER INJURY 5 0.0002
698 RENAL IMPAIRMENT 17 0.0002
699 HAEMATOCRIT DECREASED 4 0.0002
700 DELIRIUM 7 0.0002
701 WEIGHT INCREASED 45 0.0002
702 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
703 HEPATIC ENZYME ABNORMAL 1 0.0002
704 DEEP VEIN THROMBOSIS 13 0.0002
705 SYNCOPE 20 0.0002
706 HYPOTHERMIA 2 0.0002
707 CARDIOVASCULAR DISORDER 5 0.0002
708 OEDEMA PERIPHERAL 24 0.0002
709 SUBARACHNOID HAEMORRHAGE 2 0.0002
710 MOTOR DYSFUNCTION 2 0.0002
711 ENDOCARDITIS 1 0.0002
712 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
713 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
714 CEREBRAL ISCHAEMIA 1 0.0002
715 FOETAL DEATH 1 0.0002
716 TENDERNESS 2 0.0002
717 TACHYCARDIA 17 0.0002
718 HEPATIC ENZYME INCREASED 13 0.0002
719 GASTRITIS 5 0.0002
720 ANORECTAL DISCOMFORT 1 0.0002
721 COMPRESSION FRACTURE 1 0.0002
722 HYDROCEPHALUS 1 0.0002
723 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
724 ASPIRATION 2 0.0002
725 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
726 VIRAL INFECTION 6 0.0002
727 BLOOD CALCIUM DECREASED 2 0.0002
728 HEMIPARESIS 3 0.0002
729 MITRAL VALVE INCOMPETENCE 2 0.0002
730 PAIN IN JAW 5 0.0002
731 CHOLECYSTITIS ACUTE 1 0.0002
732 BLOOD URIC ACID INCREASED 1 0.0002
733 GENERAL PHYSICAL HEALTH DETERIORATION 20 0.0002
734 LIVER FUNCTION TEST ABNORMAL 5 0.0002
735 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
736 BONE PAIN 10 0.0002
737 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
738 BLOOD CREATININE INCREASED 11 0.0002
739 ISCHAEMIC STROKE 3 0.0002
740 GALLBLADDER DISORDER 3 0.0002
741 PRODUCTIVE COUGH 8 0.0002
742 POLYNEUROPATHY 2 0.0002
743 ENDOPHTHALMITIS 1 0.0002
744 INFUSION RELATED REACTION 11 0.0002
745 CEREBRAL INFARCTION 4 0.0002
746 DYSURIA 6 0.0002
747 SMALL INTESTINAL OBSTRUCTION 2 0.0002
748 GENERALISED OEDEMA 2 0.0002
749 BLISTER 9 0.0002
750 FLUID RETENTION 8 0.0002
751 HYPOPHAGIA 4 0.0002
752 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
753 HAEMOGLOBIN ABNORMAL 1 0.0002
754 ANGINA UNSTABLE 1 0.0002
755 HAEMORRHOIDS 3 0.0002
756 IMMUNE SYSTEM DISORDER 2 0.0002
757 SARS-COV-2 TEST POSITIVE 2 0.0002
758 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
759 ABDOMINAL DISTENSION 15 0.0001
760 DECREASED APPETITE 33 0.0001
761 DIVERTICULUM 1 0.0001
762 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
763 PARALYSIS 2 0.0001
764 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
765 INFLAMMATION 7 0.0001
766 URINARY INCONTINENCE 4 0.0001
767 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
768 RASH MACULO-PAPULAR 3 0.0001
769 HAEMODYNAMIC INSTABILITY 1 0.0001
770 BOWEL MOVEMENT IRREGULARITY 1 0.0001
771 ABDOMINAL PAIN 30 0.0001
772 MENINGIOMA 2 0.0001
773 HAEMORRHAGIC STROKE 1 0.0001
774 GASTROINTESTINAL INFLAMMATION 1 0.0001
775 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
776 PNEUMOTHORAX 2 0.0001
777 ABSCESS 2 0.0001
778 BLOOD DISORDER 1 0.0001
779 SENSORY DISTURBANCE 2 0.0001
780 GASTROINTESTINAL DISORDER 11 0.0001
781 DECUBITUS ULCER 1 0.0001
782 BLINDNESS 5 0.0001
783 HICCUPS 1 0.0001
784 VENTRICULAR TACHYCARDIA 2 0.0001
785 EXTRAPYRAMIDAL DISORDER 3 0.0001
786 MULTI-ORGAN FAILURE 2 0.0001
787 MENTAL DISORDER 5 0.0001
788 EOSINOPHILIA 2 0.0001
789 TOXICITY TO VARIOUS AGENTS 19 0.0001
790 PRODUCT USE ISSUE 21 0.0001
791 HEAVY MENSTRUAL BLEEDING 1 0.0001
792 CONSTIPATION 24 0.0001
793 END STAGE RENAL DISEASE 2 0.0001
794 DRUG INEFFECTIVE 143 0.0001
795 AGRANULOCYTOSIS 2 0.0001
796 DEMENTIA 3 0.0001
797 WOUND 3 0.0001
798 ERYTHEMA MULTIFORME 1 0.0001
799 MUSCULOSKELETAL DISORDER 2 0.0001
800 POST PROCEDURAL COMPLICATION 2 0.0001
801 PRESCRIBED OVERDOSE 2 0.0001
802 ATRIAL FIBRILLATION 10 0.0001
803 TREMOR 17 0.0001
804 DIARRHOEA 66 0.0001
805 VOMITING 48 0.0001
806 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
807 PSYCHOTIC DISORDER 3 0.0001
808 HOSPICE CARE 1 0.0001
809 BRAIN INJURY 1 0.0001
810 URINARY TRACT INFECTION 17 0.0001
811 EAR DISCOMFORT 1 0.0001
812 HAEMORRHAGE 10 0.0001
813 AGITATION 7 0.0001
814 MOUTH ULCERATION 2 0.0001
815 NAUSEA 75 0.0001
816 RENAL FAILURE ACUTE 4 0.0001
817 EATING DISORDER 2 0.0001
818 DRUG INTOLERANCE 9 0.0001
819 WEIGHT DECREASED 26 0.0001
820 PRODUCT USE IN UNAPPROVED INDICATION 23 0.0001
821 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
822 OSTEONECROSIS 3 0.0001
823 FATIGUE 71 0.0001
824 DENTAL CARIES 1 0.0001
825 TOOTH DISORDER 2 0.0001
826 URINARY RETENTION 3 0.0001
827 PULMONARY OEDEMA 4 0.0001
828 ORAL PAIN 2 0.0001
829 OXYGEN SATURATION DECREASED 5 0.0001
830 CHROMATURIA 2 0.0001
831 DERMATITIS CONTACT 1 0.0001
832 CARDIAC FAILURE 7 0.0001
833 HERPES ZOSTER 5 0.0001
834 LETHARGY 5 0.0001
835 DYSPHAGIA 8 0.0001
836 CONTUSION 8 0.0001
837 PRESYNCOPE 2 0.0001
838 RESTLESSNESS 3 0.0001
839 PNEUMONIA ASPIRATION 2 0.0001
840 DYSARTHRIA 3 0.0001
841 BLOOD GLUCOSE INCREASED 15 0.0001
842 HAEMATEMESIS 2 0.0001
843 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
844 MYALGIA 13 0.0001
845 DEHYDRATION 10 0.0001
846 HEADACHE 47 0.0001
847 ABORTION SPONTANEOUS 3 0.0001
848 PALLOR 2 0.0001
849 SKIN LESION 2 0.0001
850 HAEMATOCHEZIA 4 0.0001
851 POLLAKIURIA 3 0.0001
852 DEVICE OCCLUSION 1 0.0001
853 BLINDNESS UNILATERAL 1 0.0001
854 BRONCHOSPASM 1 0.0001
855 ANGINA PECTORIS 2 0.0001
856 HYPERTHYROIDISM 1 0.0001
857 DYSSTASIA 2 0.0001
858 NASAL CONGESTION 4 0.0001
859 LABORATORY TEST ABNORMAL 2 0.0001
860 CARDIOMYOPATHY 1 0.0001
861 COLITIS ULCERATIVE 3 0.0001
862 COLON CANCER 1 0.0001
863 RESPIRATORY DISORDER 2 0.0001
864 HALLUCINATION 5 0.0001
865 ADVERSE EVENT 6 0.0001
866 CEREBROVASCULAR ACCIDENT 11 0.0001
867 EJECTION FRACTION DECREASED 1 0.0001
868 COGNITIVE DISORDER 3 0.0001
869 COUGH 18 0.0001
870 SWOLLEN TONGUE 2 0.0001
871 CYANOSIS 1 0.0001
872 ARRHYTHMIA 3 0.0001
873 COMA 3 0.0001
874 CYSTITIS 2 0.0001
875 HYPOTHYROIDISM 2 0.0001
876 BLOOD POTASSIUM INCREASED 1 0.0001
877 SWELLING FACE 4 0.0001
878 CHOLELITHIASIS 2 0.0001
879 DRUG LEVEL INCREASED 1 0.0001
880 SKIN DISORDER 2 0.0001
881 MALAISE 26 0.0001
882 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
883 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
884 DEVICE USE ERROR 2 0.0001
885 AMENORRHOEA 1 0.0001
886 CONDITION AGGRAVATED 17 0.0001
887 ADVERSE DRUG REACTION 5 0.0001
888 DRUG EFFECT INCOMPLETE 2 0.0001
889 RASH 24 0.0001
890 BONE DISORDER 1 0.0001
891 LOSS OF CONSCIOUSNESS 7 0.0001
892 OROPHARYNGEAL PAIN 5 0.0001
893 HEPATIC STEATOSIS 1 0.0001
894 NECK PAIN 3 0.0001
895 ASTHENIA 20 0.0001
896 DYSPNOEA EXERTIONAL 2 0.0001
897 BLOOD SODIUM DECREASED 1 0.0001
898 FRACTURE 1 0.0001
899 PLASMA CELL MYELOMA 2 0.0001
900 DYSPNOEA 29 0.0001
901 THROMBOSIS 4 0.0000
902 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
903 THERAPEUTIC RESPONSE DECREASED 3 0.0000
904 FEEDING DISORDER 1 0.0000
905 INSOMNIA 13 0.0000
906 SINUSITIS 5 0.0000
907 INFLUENZA LIKE ILLNESS 4 0.0000
908 CARDIAC ARREST 4 0.0000
909 FALL 16 0.0000
910 HALLUCINATION, VISUAL 1 0.0000
911 GAIT DISTURBANCE 9 0.0000
912 IMPAIRED WORK ABILITY 1 0.0000
913 RECTAL HAEMORRHAGE 2 0.0000
914 DEVICE LEAKAGE 2 0.0000
915 BLOOD PRESSURE DECREASED 3 0.0000
916 INFLUENZA 5 0.0000
917 PARAESTHESIA 7 0.0000
918 HEART RATE IRREGULAR 1 0.0000
919 TINNITUS 2 0.0000
920 RENAL DISORDER 2 0.0000
921 HYPERTENSION 9 0.0000
922 HEPATIC CANCER 1 0.0000
923 DYSPEPSIA 4 0.0000
924 DIZZINESS 20 0.0000
925 AGEUSIA 1 0.0000
926 HYPOAESTHESIA 6 0.0000
927 DIABETES MELLITUS 3 0.0000
928 BLOOD PRESSURE INCREASED 6 0.0000
929 CHEST DISCOMFORT 4 0.0000
930 ILLNESS 4 0.0000
931 ANAPHYLACTIC SHOCK 1 0.0000
932 DEAFNESS 1 0.0000
933 CHEST PAIN 7 0.0000
934 DISTURBANCE IN ATTENTION 2 0.0000
935 HAEMOPTYSIS 1 0.0000
936 EYE PAIN 2 0.0000
937 ANXIETY 10 0.0000
938 HYPERSOMNIA 1 0.0000
939 DYSPHONIA 2 0.0000
940 CORONARY ARTERY DISEASE 1 0.0000
941 ILL-DEFINED DISORDER 2 0.0000
942 PAIN 20 0.0000
943 AMNESIA 2 0.0000
944 PAIN IN EXTREMITY 9 0.0000
945 HEART RATE INCREASED 3 0.0000
946 BACK PAIN 7 0.0000
947 EXPIRED PRODUCT ADMINISTERED 1 0.0000
948 ABDOMINAL PAIN UPPER 6 0.0000
949 MEMORY IMPAIRMENT 4 0.0000
950 ARTHRALGIA 12 0.0000
951 MYOCARDIAL INFARCTION 5 0.0000
952 HEART RATE DECREASED 1 0.0000
953 ACCIDENTAL OVERDOSE 1 0.0000
954 UNEVALUABLE EVENT 2 0.0000
955 CHRONIC KIDNEY DISEASE 2 0.0000
956 DRUG INTERACTION 4 0.0000
957 SOMNOLENCE 5 0.0000
958 VISUAL IMPAIRMENT 3 0.0000
959 CARDIO-RESPIRATORY ARREST 1 0.0000
960 HYPOACUSIS 1 0.0000
961 PRODUCT STORAGE ERROR 2 0.0000
962 CARDIAC DISORDER 2 0.0000
963 PULMONARY EMBOLISM 2 0.0000
964 HYPOGLYCAEMIA 1 0.0000
965 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
966 DEPRESSED MOOD 1 0.0000
967 BRADYCARDIA 1 0.0000
968 ANAPHYLACTIC REACTION 1 0.0000
969 INCORRECT DOSE ADMINISTERED 4 0.0000
970 CONVULSION 1 0.0000
971 FEELING ABNORMAL 4 0.0000
972 DISCOMFORT 1 0.0000
973 INJECTION SITE ERYTHEMA 2 0.0000
974 HYPERHIDROSIS 2 0.0000
975 ERYTHEMA 3 0.0000
976 VISION BLURRED 2 0.0000
977 HOT FLUSH 1 0.0000
978 DEPRESSION 3 0.0000
979 PERIPHERAL SWELLING 2 0.0000
980 INJECTION SITE HAEMORRHAGE 1 0.0000
981 CARDIAC FAILURE CONGESTIVE 1 0.0000
982 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
983 BALANCE DISORDER 1 0.0000
984 INTENTIONAL PRODUCT MISUSE 1 0.0000
985 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
986 HYPERSENSITIVITY 2 0.0000
987 ALOPECIA 2 0.0000
988 DRY SKIN 1 0.0000
989 PRODUCT DOSE OMISSION ISSUE 2 0.0000
990 HOSPITALISATION 1 0.0000
991 PRURITUS 2 0.0000